Biolin Investment Limited to acquire BeyondSpring Ltd.

Biolin Investment Limited has agreed to acquire the assets of BeyondSpring Ltd. in a healthcare sector transaction. The deal was announced on 29 September 2026 and completed the following day, on 30 September 2026. The buyer is based in Hong Kong, while the target company is located in the British Virgin Islands. The consideration for this asset sale is structured as deferred payment. No specific monetary value for the transaction has been disclosed or reported in the available data. The completion of the deal marks the successful transfer of the specified assets from the target to the buyer. This transaction represents a standard asset purchase rather than a full equity acquisition. The parties have finalized all necessary steps to conclude the agreement. The process moved swiftly from announcement to completion within a single day. There are no reported regulatory hurdles that delayed the closing of this specific deal. The healthcare sector context provides the industry framework for this corporate action. The deferred nature of the payment suggests a structured financial arrangement between the two entities. This summary reflects only the confirmed facts provided in the deal records. No further details on the specific assets transferred are available in the current dataset. The transaction status is recorded as completed.